At Fondazione Italiana Fegato, we are dedicated to advancing research and awareness around liver diseases in Italy and beyond. Our mission is to promote scientific studies, provide education, and support patients dealing with liver conditions. We collaborate with healthcare professionals, researchers, and institutions to drive innovation and enhance the quality of life for those affected. Together, we strive to foster a healthier future through our commitment to liver health and disease prevention.
Fondazione Italiana Fegato (FIF) is a non-profit research organisation in Trieste, Italy. Its MASLD Unit investigates the mechanisms of liver disease, develops non-invasive biomarkers, and evaluates metabolic interventions for obesity and type 2 diabetes.
Partner seeks Consortium/Coordinator
Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Author
Senior researcher -MASLD UNit at Fondazione Italiana Fegato
Fondazione Italiana Fegato is based in Italy, focused on translational hepatology. We study MASLD in the context of obesity, T2DM, and cardiometabolic conditions, with an emphasis on biomarker discovery, disease mechanisms, and response to interventions.
Partner seeks Consortium/Coordinator
Destination 3: HORIZON-HLTH-2027-02-DISEASE-01-two-stage: Innovative healthcare interventions for non-communicable diseases
Destination 3: HORIZON-HLTH-2027-01-DISEASE-10: Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Destination 5: HORIZON-HLTH-2027-02-TOOL-01-two-stage: Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases